Skip to main content
Erschienen in: Digestive Diseases and Sciences 4/2017

22.02.2017 | Review

Pain in Patients with Pancreatic Cancer: Prevalence, Mechanisms, Management and Future Developments

verfasst von: Andreas I. Koulouris, Paul Banim, Andrew R. Hart

Erschienen in: Digestive Diseases and Sciences | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Pain affects approximately 80% of patients with pancreatic cancer, with half requiring strong opioid analgesia, namely: morphine-based drugs on step three of the WHO analgesic ladder (as opposed to the weak opioids: codeine and tramadol). The presence of pain is associated with reduced survival. This article reviews the literature regarding pain: prevalence, mechanisms, pharmacological, and endoscopic treatments and identifies areas for research to develop individualized patient pain management pathways. The online literature review was conducted through: PubMed, Clinical Key, Uptodate, and NICE Evidence. There are two principal mechanisms for pain: pancreatic duct obstruction and pancreatic neuropathy which, respectively, activate mechanical and chemical nociceptors. In pancreatic neuropathy, several histological, molecular, and immunological changes occur which correlate with pain including: transient receptor potential cation channel activation and mast cell infiltration. Current pain management is empirical rather etiology-based and is informed by the WHO analgesic ladder for first-line therapies, and then endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN) in patients with resistant pain. For EUS-CPN, there is only one clinical trial reporting a benefit, which has limited generalizability. Case series report pancreatic duct stenting gives effective analgesia, but there are no clinical trials. Progress in understanding the mechanisms for pain and when this occurs in the natural history, together with assessing new therapies both pharmacological and endoscopic, will enable individualized care and may improve patients’ quality of life and survival.
Literatur
3.
Zurück zum Zitat Freelove R, Waling AD. Pancreatic cancer: diagnosis and management. Am Fam Physician. 2006;73:485–492.PubMed Freelove R, Waling AD. Pancreatic cancer: diagnosis and management. Am Fam Physician. 2006;73:485–492.PubMed
4.
Zurück zum Zitat Moore JC, Adler DG. Celiac plexus neurolysis for pain relief in pancreatic cancer. Support Oncol. 2009;7:83–87. Moore JC, Adler DG. Celiac plexus neurolysis for pain relief in pancreatic cancer. Support Oncol. 2009;7:83–87.
5.
Zurück zum Zitat Moningi S, Walker AJ, Hsu CC, et al. Correlation of clinical stage and performance status with quality of life in patients seen in a pancreas multidisciplinary clinic. J Oncol Pract. 2014;112:e216–e221. Moningi S, Walker AJ, Hsu CC, et al. Correlation of clinical stage and performance status with quality of life in patients seen in a pancreas multidisciplinary clinic. J Oncol Pract. 2014;112:e216–e221.
6.
Zurück zum Zitat Müller F, Köninger M, Wente H, Ceyhan B, Kleeff B. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. Am J Surg. 2008;195:221–228.CrossRefPubMed Müller F, Köninger M, Wente H, Ceyhan B, Kleeff B. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. Am J Surg. 2008;195:221–228.CrossRefPubMed
7.
Zurück zum Zitat Barreto SG, Saccone GTP. Pancreatic nociception—revisiting the physiology and pathophysiology. Pancreatology. 2012;12:104–112.CrossRefPubMed Barreto SG, Saccone GTP. Pancreatic nociception—revisiting the physiology and pathophysiology. Pancreatology. 2012;12:104–112.CrossRefPubMed
8.
Zurück zum Zitat Sharaiha R, Widmer J, Kahaleh K. Palliation of pancreatic ductal obstruction in pancreatic cancer. Gastrointest Endosc Clin N Am. 2013;23:917–923.CrossRefPubMed Sharaiha R, Widmer J, Kahaleh K. Palliation of pancreatic ductal obstruction in pancreatic cancer. Gastrointest Endosc Clin N Am. 2013;23:917–923.CrossRefPubMed
9.
Zurück zum Zitat Wehrmann T, Riphaus F, Martchenko S. Endoscopic pancreatic duct stenting for relief of pancreatic cancer pain. Eur J Gastroenterol Hepatol. 2005;17:1395–1400.CrossRefPubMed Wehrmann T, Riphaus F, Martchenko S. Endoscopic pancreatic duct stenting for relief of pancreatic cancer pain. Eur J Gastroenterol Hepatol. 2005;17:1395–1400.CrossRefPubMed
10.
Zurück zum Zitat Costamagna A, Palladino R, Mutignani M. Endoscopic pancreatic stenting in pancreatic cancer. Can J Gastroenterol. 1999;13:481–487.CrossRefPubMed Costamagna A, Palladino R, Mutignani M. Endoscopic pancreatic stenting in pancreatic cancer. Can J Gastroenterol. 1999;13:481–487.CrossRefPubMed
11.
Zurück zum Zitat Ceyhan GO, Bergmann F, Kadihasanoglu M, et al. Pancreatic neuropathy and neuropathic pain—a comprehensive pathomorphological study of 546 cases. Gastroenterology. 2009;136:177–186.CrossRefPubMed Ceyhan GO, Bergmann F, Kadihasanoglu M, et al. Pancreatic neuropathy and neuropathic pain—a comprehensive pathomorphological study of 546 cases. Gastroenterology. 2009;136:177–186.CrossRefPubMed
12.
Zurück zum Zitat di Mola FF, di Sebastiano P. Pain and pain generation in pancreatic cancer. Langenbecks Arch Surg. 2008;393:919–922.CrossRefPubMed di Mola FF, di Sebastiano P. Pain and pain generation in pancreatic cancer. Langenbecks Arch Surg. 2008;393:919–922.CrossRefPubMed
13.
Zurück zum Zitat Hartel M, Di Mola FF, Selvaggi F, et al. Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut. 2006;55:519–528.CrossRefPubMedPubMedCentral Hartel M, Di Mola FF, Selvaggi F, et al. Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut. 2006;55:519–528.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Demir IE, Schorn S, Schremmer-Danninger E, et al. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis. PLoS One. 2013;8:60529.CrossRef Demir IE, Schorn S, Schremmer-Danninger E, et al. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis. PLoS One. 2013;8:60529.CrossRef
15.
Zurück zum Zitat Hameed M, Hameed H, Erdek M. Pain management in pancreatic cancer. Cancers (Basel). 2010;3:43–60.CrossRef Hameed M, Hameed H, Erdek M. Pain management in pancreatic cancer. Cancers (Basel). 2010;3:43–60.CrossRef
16.
Zurück zum Zitat Esin E, Yalcin S. Neuropathic cancer pain: What we are dealing with? How to manage it? Oncol Targets Therapy. 2014;17:599–618. Esin E, Yalcin S. Neuropathic cancer pain: What we are dealing with? How to manage it? Oncol Targets Therapy. 2014;17:599–618.
18.
Zurück zum Zitat Luz L, Al-Haddad M, DeWitt JA. EUS-guided celiac plexus interventions in pancreatic cancer pain: an update and controversies for the endosonographer. Endosc Ultrasound. 2014;3:213–220.CrossRefPubMedPubMedCentral Luz L, Al-Haddad M, DeWitt JA. EUS-guided celiac plexus interventions in pancreatic cancer pain: an update and controversies for the endosonographer. Endosc Ultrasound. 2014;3:213–220.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Nagels W, Pease N, Bekkering G, Cools F, Dobbels P. celiac plexus neurolysis for abdominal cancer pain: a systematic review. Pain Med Oxf J. 2013;14:1140–1163.CrossRef Nagels W, Pease N, Bekkering G, Cools F, Dobbels P. celiac plexus neurolysis for abdominal cancer pain: a systematic review. Pain Med Oxf J. 2013;14:1140–1163.CrossRef
20.
Zurück zum Zitat Kambadakone A, Thabet A, Gervais DA, Mueller PR, Arellano RS. CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics. 2011;31:1599–1621.CrossRefPubMed Kambadakone A, Thabet A, Gervais DA, Mueller PR, Arellano RS. CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics. 2011;31:1599–1621.CrossRefPubMed
21.
Zurück zum Zitat Sahai AV, Lemelin V, Lam E, Paquin SC. Central vs. bilateral endoscopic ultrasound-guided celiac plexus block or neurolysis: a comparative study of short-term effectiveness. Am J Gastroenterol. 2009;104:326–329.CrossRefPubMed Sahai AV, Lemelin V, Lam E, Paquin SC. Central vs. bilateral endoscopic ultrasound-guided celiac plexus block or neurolysis: a comparative study of short-term effectiveness. Am J Gastroenterol. 2009;104:326–329.CrossRefPubMed
22.
Zurück zum Zitat Sakamoto H, Kitano M, Kamata K, et al. EUS-guided broad plexus neurolysis over the superior mesenteric artery using a 25-gauge needle. Am J Gastroenterol. 2010;105:2599–2606.CrossRefPubMed Sakamoto H, Kitano M, Kamata K, et al. EUS-guided broad plexus neurolysis over the superior mesenteric artery using a 25-gauge needle. Am J Gastroenterol. 2010;105:2599–2606.CrossRefPubMed
23.
Zurück zum Zitat Mittal KM. Pearls & oysters: acute spinal cord infarction following endoscopic ultrasound-guided celiac plexus neurolysis. Neurology. 2012;78:57–59.CrossRef Mittal KM. Pearls & oysters: acute spinal cord infarction following endoscopic ultrasound-guided celiac plexus neurolysis. Neurology. 2012;78:57–59.CrossRef
24.
Zurück zum Zitat Fujii L, Clain JE, Morris JM, Levy MJ. Anterior spinal cord infarction with permanent paralysis following endoscopic ultrasound celiac plexus neurolysis. Endoscopy. 2012;44:255–256.CrossRef Fujii L, Clain JE, Morris JM, Levy MJ. Anterior spinal cord infarction with permanent paralysis following endoscopic ultrasound celiac plexus neurolysis. Endoscopy. 2012;44:255–256.CrossRef
25.
Zurück zum Zitat Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV. Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol. 2011;29:3541–3546.CrossRefPubMed Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV. Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol. 2011;29:3541–3546.CrossRefPubMed
26.
Zurück zum Zitat Puli SR, Reddy JBK, et al. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci. 2009;54:2330–2337.CrossRefPubMed Puli SR, Reddy JBK, et al. EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain: a meta-analysis and systematic review. Dig Dis Sci. 2009;54:2330–2337.CrossRefPubMed
27.
Zurück zum Zitat Kaufman M, Singh G, Das S, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010;44:127–134.CrossRefPubMed Kaufman M, Singh G, Das S, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol. 2010;44:127–134.CrossRefPubMed
28.
Zurück zum Zitat Iwata K, Yasuda I, Enya M, et al. Predictive factors for pain relief after endoscopic ultrasound-guided celiac plexus neurolysis. Dig Endosc. 2011;23:140–145.CrossRefPubMed Iwata K, Yasuda I, Enya M, et al. Predictive factors for pain relief after endoscopic ultrasound-guided celiac plexus neurolysis. Dig Endosc. 2011;23:140–145.CrossRefPubMed
29.
Zurück zum Zitat Ascunce G, Ribeiro A, Reis I, et al. EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy. Gastrointest Endosc. 2011;73:267–274.CrossRefPubMed Ascunce G, Ribeiro A, Reis I, et al. EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy. Gastrointest Endosc. 2011;73:267–274.CrossRefPubMed
30.
Zurück zum Zitat Kristensen A, Vagnildhaug OM, Grønberg BH, Kaasa S, Laird B, Solheim TS. Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. J Oncol Haematol. 2016;99:286–298. Kristensen A, Vagnildhaug OM, Grønberg BH, Kaasa S, Laird B, Solheim TS. Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review. J Oncol Haematol. 2016;99:286–298.
31.
Zurück zum Zitat Gunaratnam NT, Sarma AV, Norton ID, Wiersema MJ. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc. 2001;54:316–324.CrossRefPubMed Gunaratnam NT, Sarma AV, Norton ID, Wiersema MJ. A prospective study of EUS-guided celiac plexus neurolysis for pancreatic cancer pain. Gastrointest Endosc. 2001;54:316–324.CrossRefPubMed
32.
Zurück zum Zitat Catalano MF, Ahmed U, Chauhan SS, Patel SN, Geenen JE. Celiac plexus neurolysis (CPN) in the treatment of refractory pain of pancreatic cancer (PCA): site specific response to therapy. Gastrointest Endosc. 2005;61:AB273. Catalano MF, Ahmed U, Chauhan SS, Patel SN, Geenen JE. Celiac plexus neurolysis (CPN) in the treatment of refractory pain of pancreatic cancer (PCA): site specific response to therapy. Gastrointest Endosc. 2005;61:AB273.
33.
Zurück zum Zitat Wiersema MJ, Wiersema LM. Endosonography-guided celiac plexus neurolysis. Gastrointest Endosc. 1996;44:656–662.CrossRefPubMed Wiersema MJ, Wiersema LM. Endosonography-guided celiac plexus neurolysis. Gastrointest Endosc. 1996;44:656–662.CrossRefPubMed
Metadaten
Titel
Pain in Patients with Pancreatic Cancer: Prevalence, Mechanisms, Management and Future Developments
verfasst von
Andreas I. Koulouris
Paul Banim
Andrew R. Hart
Publikationsdatum
22.02.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 4/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4488-z

Weitere Artikel der Ausgabe 4/2017

Digestive Diseases and Sciences 4/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.